Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NARI Inari Medical	$79.97	$79.97	$39.76 ▼ $79.99	$4.68B	1.02	1.47 million shs	N/A
SNN Smith & Nephew SNATS	$29.58 +0.8%	$29.41	$23.69 ▼ $31.72	$12.85B	0.69	822,793 shs	912,076 shs
SOLV Solventum	$73.00 -0.9%	$73.98	$49.64 ▼ $85.92	$12.75B	0.55	1.10 million shs	530,918 shs
ZBH Zimmer Biomet	$94.20 +0.2%	$93.31	$89.22 ▼ $116.71	$18.60B	0.71	1.83 million shs	1.47 million shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NARI Inari Medical	0.00%	0.00%	0.00%	0.00%	+37.93%
SNN Smith & Nephew SNATS	+0.78%	-3.79%	+1.05%	+14.20%	+6.65%
SOLV Solventum	-0.93%	-1.75%	-1.93%	+10.23%	+45.85%
ZBH Zimmer Biomet	+0.22%	-1.01%	+2.22%	-3.78%	-12.33%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
NARI Inari Medical	0.2605 of 5 stars	1.1	0.0	0.0	0.0	0.0	2.5	0.6
SNN Smith & Nephew SNATS	2.8815 of 5 stars	1.0	3.0	2.5	0.0	2.3	0.0	4.4
SOLV Solventum	0.7294 of 5 stars	2.1	2.0	0.0	0.0	2.7	0.0	0.0
ZBH Zimmer Biomet	4.9506 of 5 stars	3.2	5.0	2.5	3.7	3.1	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
NARI Inari Medical	2.14	Hold	$69.22	-13.44% Downside
SNN Smith & Nephew SNATS	2.00	Hold	$28.00	-5.33% Downside
SOLV Solventum	2.27	Hold	$84.38	15.58% Upside
ZBH Zimmer Biomet	2.35	Hold	$111.39	18.25% Upside

Current Analyst Ratings Breakdown

Latest NARI, ZBH, SNN, and SOLV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	SOLV Solventum	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$80.00 ➝ $103.00
7/15/2025	ZBH Zimmer Biomet	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$135.00
7/8/2025	ZBH Zimmer Biomet	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$102.00 ➝ $96.00
7/1/2025	SOLV Solventum	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$90.00
6/6/2025	SOLV Solventum	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sector Weight
5/19/2025	SOLV Solventum	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$78.00 ➝ $87.00
5/12/2025	ZBH Zimmer Biomet	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$115.00 ➝ $101.00
5/9/2025	SOLV Solventum	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$80.00 ➝ $78.00
5/7/2025	ZBH Zimmer Biomet	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$140.00 ➝ $125.00
5/6/2025	ZBH Zimmer Biomet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$101.00
5/6/2025	ZBH Zimmer Biomet	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$138.00 ➝ $115.00

(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
NARI Inari Medical	$493.63M	9.48	$0.09 per share	906.95	$8.07 per share	9.91
SNN Smith & Nephew SNATS	$5.81B	2.23	$3.18 per share	9.29	$12.04 per share	2.46
SOLV Solventum	$8.25B	1.53	$9.85 per share	7.41	$17.13 per share	4.26
ZBH Zimmer Biomet	$7.68B	2.43	$13.21 per share	7.13	$62.67 per share	1.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
NARI Inari Medical	-$1.64M	-$1.35	N/A	727.00	N/A	-13.68%	-10.09%	-6.60%	N/A
SNN Smith & Nephew SNATS	$412M	$2.16	13.69	14.79	0.90	N/A	N/A	N/A	8/5/2025 (Estimated)
SOLV Solventum	$478M	$2.16	33.80	13.30	1.89	4.55%	31.01%	6.53%	8/4/2025 (Estimated)
ZBH Zimmer Biomet	$903.70M	$4.52	20.84	10.62	2.17	11.86%	12.73%	7.34%	8/6/2025 (Estimated)

Latest NARI, ZBH, SNN, and SOLV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	ZBH Zimmer Biomet	$1.99	N/A	N/A	N/A	$2.06 billion	N/A
5/8/2025	Q1 2025	SOLV Solventum	$1.19	$1.34	+$0.15	$0.78	$2.02 billion	$2.07 billion
5/5/2025	Q1 2025	ZBH Zimmer Biomet	$1.77	$1.81	+$0.04	$0.91	$1.89 billion	$1.91 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
NARI Inari Medical	N/A	N/A	N/A	N/A	N/A
SNN Smith & Nephew SNATS	$0.89	3.01%	N/A	41.20%	N/A
SOLV Solventum	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	1.02%	N/A	21.24%	N/A

Latest NARI, ZBH, SNN, and SOLV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/30/2025	ZBH Zimmer Biomet	quarterly	$0.24	1.03%	6/26/2025	6/26/2025	7/31/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
NARI Inari Medical	N/A	1.77	1.40
SNN Smith & Nephew SNATS	0.62	2.89	1.33
SOLV Solventum	2.40	1.19	0.85
ZBH Zimmer Biomet	0.53	2.44	1.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
NARI Inari Medical	90.98%
SNN Smith & Nephew SNATS	25.64%
SOLV Solventum	N/A
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
NARI Inari Medical	10.60%
SNN Smith & Nephew SNATS	1.00%
SOLV Solventum	0.05%
ZBH Zimmer Biomet	1.39%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
NARI Inari Medical	800	58.54 million	52.34 million	Optionable
SNN Smith & Nephew SNATS	17,349	437.97 million	433.59 million	Optionable
SOLV Solventum	22,000	173.01 million	172.93 million	Optionable
ZBH Zimmer Biomet	17,000	197.85 million	195.10 million	Optionable

NARI, ZBH, SNN, and SOLV Headlines

Recent News About These Companies

MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM

July 16 at 11:36 AM | businesswire.com

Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH)

July 16 at 10:43 AM | insidermonkey.com

Equity Investment Corp Acquires 17,286 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 16 at 8:45 AM | marketbeat.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), Zimmer Biomet Holdings (ZBH) and Eli Lilly & Co (LLY)

July 16 at 6:08 AM | theglobeandmail.com

New York State Common Retirement Fund Grows Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 16 at 4:33 AM | marketbeat.com

Zimmer Biomet enters agreement to acquire orthopaedic robotics company, Monogram Technologies

July 15 at 12:15 AM | pharmabiz.comP

Zimmer Biomet inks $177M deal for Monogram and its hands-free orthopedic robot

July 15 at 7:13 PM | fiercebiotech.comF

Zimmer Biomet wins price target raise at Roth

July 15 at 7:13 PM | cantechletter.comC

Zimmer upgraded to Buy at Roth Capital on Monogram deal

July 15 at 7:13 PM | msn.com

Bryn Mawr Capital Management LLC Boosts Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 15 at 9:40 AM | marketbeat.com

Zimmer Biomet (NYSE:ZBH) Raised to Buy at Roth Capital

July 15 at 8:43 AM | marketbeat.com

Zimmer to acquire Monogram Technologies for $177 million, boosting robotics portfolio

July 14 at 12:19 AM | msn.com

Zimmer Biomet acquisition of Monogram Technologies to expand capacity in robotics devices

July 14 at 12:19 AM | journalgazette.netJ

Zimmer Biomet to acquire Monogram Technologies for $177M

July 14 at 12:19 AM | therobotreport.comT

Monogram Technologies Shares Surge After Zimmer Biomet Announces Acquisition

July 14 at 12:19 AM | msn.com

Envestnet Asset Management Inc. Purchases 66,114 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 14 at 4:02 AM | marketbeat.com

Canaccord Genuity Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)

July 13, 2025 | theglobeandmail.com

Speece Thorson Capital Group Inc. Has $20.23 Million Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 13, 2025 | marketbeat.com

Citi Remains a Hold on Zimmer Biomet Holdings (ZBH)

July 11, 2025 | theglobeandmail.com

Country Club Bank Buys Shares of 35,777 Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 11, 2025 | marketbeat.com

Getinge, Zimmer Biomet Announce Partnership In The ASC Sector

July 10, 2025 | inkfreenews.comI

New MarketBeat Followers Over Time

Media Sentiment Over Time

NARI, ZBH, SNN, and SOLV Company Descriptions

Inari Medical NASDAQ:NARI

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Smith & Nephew SNATS NYSE:SNN

$29.58 +0.25 (+0.84%)

Closing price 07/16/2025 03:59 PM Eastern

Extended Trading

$29.57 0.00 (-0.02%)

As of 07/16/2025 04:10 PM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum NYSE:SOLV

$73.00 -0.68 (-0.92%)

Closing price 07/16/2025 03:59 PM Eastern

Extended Trading

$72.88 -0.13 (-0.17%)

As of 07/16/2025 07:57 PM Eastern

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Zimmer Biomet NYSE:ZBH

$94.20 +0.17 (+0.18%)

Closing price 07/16/2025 03:59 PM Eastern

Extended Trading

$93.80 -0.40 (-0.42%)

As of 07/16/2025 06:32 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time